Relationship between Thrombophilic Disorders and Type of Severe Early-Onset Hypertensive Disorder of Pregnancy

REFERENCES

• Sibai BM. Prevention of preeclampsia: a big disappointment. Am J Obstet Gynecol 1998; 179(5)1275–1278
   PubMed Web of Science ®Google Scholar
• Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180(2 Pt 1)499–506
   PubMed Web of Science ®Google Scholar
• Harlow FH, Brown MA. The diversity of diagnoses of preeclampsia. Hypertens Pregnancy 2001; 20(1)57–67
   PubMed Web of Science ®Google Scholar
• Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?. Am J Obstet Gynecol 1990; 162(2)311–316
   PubMed Web of Science ®Google Scholar
• Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158(4)892–898
   PubMed Web of Science ®Google Scholar
• Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customised antenatal growth charts. Lancet 1992; 339(8788)283–287
   PubMed Web of Science ®Google Scholar
• Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements—a prospective study. Am J Obstet Gynecol 1985; 151(3)333–337
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340(1)9–13
   PubMed Web of Science ®Google Scholar
• Rigo J, Jr., Nagy B, Fintor L, Tanyi J, Beke A, Karadi I, et al. Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertens Pregnancy 2000; 19(2)163–172
   PubMed Web of Science ®Google Scholar
• von Tempelhoff GF, Heilmann L, Spanuth E, Kunzmann E, Hommel G. Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-syndrome. Hemolysis, elevated liver-enzymes, low platelets. Thromb Res 2000; 100(4)363–365
   PubMedGoogle Scholar
• Van Pampus MG, Dekker GA, Wolf H, Huijgens PC, Koopman MM, Blomberg BM, et al. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol 1999; 180(5)1146–1150
   PubMed Web of Science ®Google Scholar
• Benedetto C, Marozio L, Salton L, Maula V, Chieppa G, Massobrio M. Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome. Acta Obstet Gynecol Scand 2002; 81(12)1095–1100
   PubMed Web of Science ®Google Scholar
• Schlembach D, Beinder E, Zingsem J, Wunsiedler U, Beckmann MW, Fischer T. Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction. Clin Sci (Colch) 2003; 105(3)279–285
   Google Scholar
• Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000; 96(1)45–49
   PubMedGoogle Scholar
• Dekker GA, De Vries JI, Doelitzsch PM, Huijgens PC, Von Blomberg BM, Jakobs C, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995; 173(4)1042–8
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Rimon E, Ascher-Landsberg J, Lessing JB, Many A. Perinatal outcome in women with severe pregnancy complications and multiple thrombophilias. J Perinat Med 2004; 32(3)225–227
   PubMedGoogle Scholar
• Dizon-Townson DS, Nelson LM, Easton K, Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996; 175(4 Pt 1)902–905
   PubMedGoogle Scholar
• Nagy B, Toth T, Rigo J, Jr., Karadi I, Romics L, Papp Z. Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women. Clini Genet 1998; 53(6)478–481
   PubMedGoogle Scholar
• Krauss T, Augustin HG, Osmers R, Meden H, Unterhalt M, Kuhn W. Activated protein C resistance and factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome. Obstet Gynecol 1998; 92(3)457–460
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Peri H, Zwang E, Yaron Y, Wolman I, Eldor A. High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstet Gynecol Scand 2000; 79(11)963–967
   PubMedGoogle Scholar
• Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Euro J Obstet, Gynecol Reprod Biol 2002; 101(1)6–14
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Many A, Bar-Am A, Lessing JB, Ascher-Landsberg J. Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia. Br J Obstet Gynaecol 2002; 109(12)1373–1376
   Google Scholar
• Martinelli P, Grandone E, Colaizzo D, Paladini D, Scianname N, Margaglione M, et al. Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica 2001; 86(4)428–431
   PubMedGoogle Scholar
• Verspyck E, Cam-Duchez V, Goffinet F, Tron F, Marpeau L, Borg JY. Thrombophilia and immunological disorders in pregnancies as risk factors for small for gestational age infants. Br J Obstet Gynaecol 2002; 109(1)28–33
   Google Scholar
• Ganzevoort W, Rep A, Bonsel GJ, De Vries JI, Wolf H. A randomized trial of plasma volume expansion in hypertensive disorders of pregnancy: influence on the pulsatility indices of the fetal umbilical artery and middle cerebral artery. Am J Obstet Gynecol 2005; 192(1)233–239
   PubMedGoogle Scholar
• Ganzevoort W, Rep A, Bonsel GJ, Fetter WPF, van Sonderen L, de Vries JIP, et al. A randomised controlled trial comparing a temporising management strategy with plasma volume expansion with one without plasma volume expansion. Br J Obstet Gynaecol 2005; 112: 1358–1368
   Google Scholar
• Giri TK, Hillarp A, Hardig Y, Zoller B, Dahlback B. A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen. Thromb Haemost 1998; 79(4)767–772
   PubMedGoogle Scholar
• Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 1993; 90(3)1004–1008
   PubMed Web of Science ®Google Scholar
• Voorberg J, Roelse J, Koopman R, Buller H, Berends F, ten Cate JW. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Lancet 1994; 343(8912)1535–1536
   PubMedGoogle Scholar
• Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88(10)3698–3703
   PubMed Web of Science ®Google Scholar
• Ubbink JB, Hayward Vermaak WJ, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatog 1991; 565(1–2)441–446
   PubMedGoogle Scholar
• Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74(4)1185–1190
   PubMed Web of Science ®Google Scholar
• Harris EN. Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group. Am J Clin Pathol 1990; 94(4)476–484
   PubMedGoogle Scholar
• Infante-Rivard C, Rivard GE, Yotov WV, Genin E, Guiguet M, Weinberg C, et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 2002; 347(1)19–25
   PubMed Web of Science ®Google Scholar
• Kim YJ, Williamson RA, Murray JC, Andrews J, Pietscher JJ, Peraud PJ, et al. Genetic susceptibility to preeclampsia: roles of cytosineto-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation. Am J Obstet Gynecol 2001; 184(6)1211–1217
   PubMedGoogle Scholar
• Livingston JC, Barton JR, Park V, Haddad B, Phillips O, Sibai BM. Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am J Obstet Gynecol 2001; 185(1)153–157
   PubMed Web of Science ®Google Scholar
• Currie L, Peek M, McNiven M, Prosser I, Mansour J, Ridgway J. Is there an increased maternal-infant prevalence of Factor V Leiden in association with severe pre-eclampsia?. Br J Obstet Gynaecol 2002; 109(2)191–196
   Google Scholar
• Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, et al. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 2002; 87(5)779–785
   PubMedGoogle Scholar
• KM O'shaughnessy, Fu B, Ferraro F, Lewis I, Downing S, Morris NH. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. Hypertension 1999; 33(6)1338–1341
   PubMedGoogle Scholar
• De Groot CJ, Bloemenkamp KW, Duvekot EJ, Helmerhorst FM, Bertina RM, Van Der MF, et al. Preeclampsia and genetic risk factors for thrombosis: a case-control study. Am J Obstet Gynecol 1999; 181(4)975–980
   PubMed Web of Science ®Google Scholar
• Lin J, August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 2005; 105(1)182–192
   PubMed Web of Science ®Google Scholar
• Kosmas IP, Tatsioni A, Ioannidis JP. Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens 2003; 21(7)1221–1228
   PubMed Web of Science ®Google Scholar
• Kosmas IP, Tatsioni A, Ioannidis JP. Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens 2004; 22(9)1655–1662
   PubMedGoogle Scholar
• Pabinger I, Vormittag R. Thrombophilia and pregnancy outcomes. Journal of Thrombosis and Haemostasis 2005; 3(8)1603–1610
   PubMedGoogle Scholar
• Greer IA. Thrombophilia: implications for pregnancy outcome. Thromb Res 2003; 109(2–3)73–81
   PubMedGoogle Scholar
• De Vries JI, Dekker GA, Huijgens PC, Jakobs C, Blomberg BM, Van Geijn HP. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies. Br J Obstet Gynaecol 1997; 104(11)1248–1254
   PubMedGoogle Scholar
• Bodnar LM, Ness RB, Markovic N, Roberts JM. The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol 2005; 15(7)475–482
   PubMed Web of Science ®Google Scholar
• Ganzevoort W, Rep A, De Vries JI, Bonsel GJ, Wolf H. for the PETRA investigators. Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy. Am J Obstet Gynecol 2006; 195(2)495–503
   PubMedGoogle Scholar